News Archives - Page 289 of 757

MondayAug 08, 2022 9:45 am

Correlate Infrastructure Partners Inc. (CIPI) Empowering Investors, Commercial Real Estate Owners to Profitably Implement Sustainable Practices and Realize Returns

Correlate Infrastructure Partners is a portfolio-scale development and finance platform that offers a complete suite of clean energy solutions for the commercial real estate industry A report by the investment managers at Morgan Stanley’s Real Estate Investing (“MSREI”) arm established that sustainable practices drive the value of real estate Their analysis, which focused on five financial indicators – revenue, operating expenses, financing cost, leasing expenses, and property value – documented how investors can draw additional value from sustainability investments Correlate is enabling commercial real estate owners and investors to realize monetize benefits by financing, designing, building, and maintaining building efficiency…

MondayAug 08, 2022 9:00 am

FingerMotion Inc. (NASDAQ: FNGR) Making the Most of Massive Cell Phone Services Opportunities in Chinese Market

China has long been a telecommunications juggernaut market thanks to its nearly 1.5 billion population and the popularity of using multiple mobile devices among its people U.S.-based communications technology services provider FingerMotion has focused on delivering a variety of telecommunications services to the Chinese market, ranging from SMS texting to big data analysis FingerMotion recently reported important quarterly revenues from its operation despite a new series of lockdowns resulting from China’s zero-tolerance policy toward the COVID pandemic The company continues to explore new growth opportunities, such as a device protection service it rolled out in July that will exceed the…

FridayAug 05, 2022 10:30 am

Microdose Psychedelic Capital Conference Insights

Microdose Psychedelic Insights, the premier global guide to the business of psychedelics, hosted a successful Psychedelic Capital Conference in an entirely virtual format, Tuesday, July 26, 2022. The July edition of the Microdose event introduced the investors and attendees to top investors, entrepreneurs, psychedelic researchers, latest IPO and health leaders, sharing valuable insights into the psychedelic sector. Part of a bimonthly investor conference series that dives deep into psychedelic medicine investment, this event was focused on driving the psychedelic industry to the forefront of modern medicine. CEOs, capital advisors, analysts, and investment luminaries from across the global spectrum, shared valuable…

FridayAug 05, 2022 9:45 am

Lidar Pioneer and Cepton, Inc. (NASDAQ: CPTN) CEO Dr. Jun Pei Aims to Make Driving Safer with Lidar

Lidar provides high-precision 3D imaging that helps enable hands-free driving, autonomous vehicles, smart cities, robotics, and other smart infrastructure applications Cepton CEO Dr. Jun Pei, a pioneer who led the development of the revolutionary lidar during his tenure at Velodyne, was one of the first to focus on the ADAS market to bring lidar to the mass market Lidar is expected to be a $50B+ market by 2030 and Cepton’s technology will be in select General Motors cars starting next year Cepton recently grew its presence in Detroit with a new center of excellence and aims to expand active engagements…

FridayAug 05, 2022 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Anticipates Strongest Balance Sheet Ever as EV Industry Projected to See Double-Digit Growth

A recent Facts & Factors study reported that the global EV market is expected to pass $980 billion by 2028 Mullen posted the strongest balance sheet in company history for the quarter ended June 30, 2022 The company noted several key milestones in its journey to becoming a major presence in the EV world If Mullen Automotive (NASDAQ: MULN) latest financial report is any indication, the double-digit growth projected for the electric vehicle (“EV”) industry is right on the money. The emerging electric vehicle manufacturer posted a record balance sheet for the quarter ended June 30, 2022 (https://ibn.fm/RmJq8). A recent…

ThursdayAug 04, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Drug Product Testing Aims to Give Military Veterans New Weapon for Fighting Brain Injury

The medical care needs of military personnel are once again in the spotlight following a political dust-up over service members’ exposure to environmental hazards at burn pits Another long-standing concern among service personnel is the treatment of concussive brain injuries Although no FDA-approved prescription drug currently exists for treating concussions, medical product developer Odyssey Health Inc. is testing a device-drug combination designed to stop concussion injury in its tracks to avoid long-term harm Odyssey Health’s product would use an inhaler-like device to deliver the special medication into the nasal cavity for better uptake into the central nervous system, keying on…

ThursdayAug 04, 2022 10:00 am

Esports Market to Hit $12.5 Billion by 2030, Golden Matrix Group Inc. (NASDAQ: GMGI) To Add New Platform to Growing B2B iGaming Portfolio

Esports industry maturing, attracting growing audience via star-studded tournaments, ticket sales, merchandise, live social media events Industry expected to reach $12.5 billion at a CAGR of 21.9% by 2030 GMGI recently featured on Benzinga’s Esports Listmakers Series, CEO reveals upcoming launch of Esports platform GMGI delivers easily customizable, configurable, modular solutions for B2B operators, recently achieved 15 consecutive profitable quarters The global Esports market is maturing into a multi-faceted entertainment enterprise, complete with tournaments, celebrities, and social media influencers. Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, aims to leverage this…

ThursdayAug 04, 2022 9:30 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Maintains $100 Million 2022 Revenue Projections; Attributes it to Strong Foundation Laid Down So Far

Eat Well’s goal of investing in the entire plant-based supply chain has seen it acquire Belle Pulses Ltd., Sapientia, and 51% of Amara Organic Foods It has also seen the company invest in the CPG sector, food technology, agribusiness, and the media sectors in what the management describes as a strong foundation within its investment platform The company recognizes the ongoing global supply chain challenges brought about by the COVID-19 pandemic, as well as the ongoing Russia-Ukraine war, as an opportunity to grow its market share and address an unfulfilled demand for its products It maintains its 2022 revenue projections…

ThursdayAug 04, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advances Drug Candidate to Fight Aggressive Brain Cancer Amid Difficult Era for Market

CNS Pharmaceuticals is a U.S.-based drug innovator developing novel chemotherapy agents capable of taking the fight against cancerous tumors across the blood-brain barrier to directly attack cancerous growths of the central nervous system The company’s lead candidate is an anthracycline named Berubicin, which has previously shown promise among glioblastoma (“GBM”) patients in a safety study — particularly for one who remains cancer-free more than 15 years later CNS is enrolling patients in the United States, Italy, France, Spain, and Switzerland, for the global Phase 2 clinical trial to measure Berubicin’s potential to match or exceed the effectiveness of Lomustine, a…

WednesdayAug 03, 2022 12:00 pm

Silo Pharma Inc.’s (SILO) Ketamine Study Produces Positive Endpoint Results, Suggests Topical Formulation Reduces Neuropathic Nerve Pain

Silo recently completed ketamine study showing neuropathic nerve pain reduction when administered with patented, partnered delivery system Results of study demonstrated Silo’s topical ketamine formulation reduced mechanical allodynia and hyperalgesia at both the pre-and post-dosing time points, mechanical hyperalgesia reduced on day seven at the pre-dose time point Ketamine typically used to induce and maintain anesthesia, drug use expanding to include depression and chronic pain treatment at subanesthetic doses Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company, recently completed a study of its ketamine formulation, showing nerve pain reduction when administered using a patented delivery system developed in partnership…

Site Search

Company Search

Category: News